Valuation: Sartorius Stedim Biotech

Market Cap 16.22B 18.66B 15.1B 13.86B 26.17B 1,781B 26.58B 178B 69.84B 887B 70.07B 68.53B 2,973B P/E 2026 *
42.9x
P/E 2027 * 33.2x
Enterprise Value 18.23B 20.97B 16.97B 15.58B 29.42B 2,002B 29.88B 200B 78.5B 997B 78.76B 77.03B 3,342B EV / Sales 2026 *
5.83x
EV / Sales 2027 * 5.19x
Free-Float
28.47%
Yield 2026 *
0.5%
Yield 2027 * 0.61%
1 day+3.48%
1 week+6.02%
Current month+3.48%
1 month-4.27%
3 months+10.93%
6 months-10.16%
Current year-17.86%
1 week 161.2
Extreme 161.2
174.6
1 month 158.9
Extreme 158.9
190.8
Current year 150
Extreme 150
224
1 year 150
Extreme 150
224
3 years 139.1
Extreme 139.1
281
5 years 139.1
Extreme 139.1
551
10 years 50.13
Extreme 50.13
551
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Date Insider Type Main position Quantity % Market Cap.
12/17/25 SellCompany 750,000 0.7706%
2/16/24 Buy

Chief Executive Officer

1,716,739 1.8624%
3/2/22 SellCompany 200,442 0.2174%
Change 5-day change 1-year change 3-year change Capi.($)
+3.48%+6.02%+1.47%-36.23% 18.66B
+1.14%+2.29%-17.74%-0.61% 183B
+0.99%+2.36%-3.83%+2.04% 109B
+0.07%+0.01%+5.98%+62.62% 60.57B
+2.37%+2.85%+44.34%+56.22% 51.8B
+1.67%+5.85%-5.97%-37.39% 45.64B
+3.25%+2.40% - - 33.22B
+2.83%+16.71%+12.30%-29.85% 31.49B
+1.81%+4.86%+45.71%-6.05% 24B
+1.39%+5.94%+1.29%+2.61% 22.26B
Average +1.91%+4.03%+9.28%+1.48% 57.98B
Weighted average by Cap. +1.50%+3.25%+0.48%+6.23%

Financials

2026 *2027 *
Net sales 3.13B 3.6B 2.91B 2.67B 5.05B 343B 5.12B 34.31B 13.47B 171B 13.51B 13.21B 573B 3.47B 3.99B 3.23B 2.96B 5.59B 381B 5.68B 38.03B 14.93B 190B 14.98B 14.65B 635B
Net income 376M 433M 350M 322M 607M 41.32B 617M 4.13B 1.62B 20.57B 1.63B 1.59B 68.97B 480M 553M 447M 411M 775M 52.76B 787M 5.27B 2.07B 26.27B 2.08B 2.03B 88.08B
Net Debt 2.01B 2.31B 1.87B 1.72B 3.24B 221B 3.3B 22.06B 8.66B 110B 8.69B 8.5B 369B 1.77B 2.03B 1.65B 1.51B 2.85B 194B 2.9B 19.4B 7.62B 96.68B 7.64B 7.47B 324B
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
10,477
Date Price Change Volume
26-08-03 172.50 +3.48% 23,686
26-07-31 €166.70 -2.00% 137,690
26-07-30 €170.10 -0.64% 57,064
26-07-29 €171.20 +0.71% 86,575
26-07-28 €170.00 +4.49% 102,868
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
166.70EUR
Average target price
229.79EUR
Spread / Average Target
+37.84%

Quarterly revenue - Rate of surprise